Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 279

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1
Chunk 279
---
    10-Q
     
    001-14895
     
    10.6
     
    8/8/18

     10.34†
     
    Form of Stock Option Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    10/31/18

-88-

     10.35†
     
    Form of Restricted Stock Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.2
     
    10/31/18

     10.36†
     
    Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.3
     
    10/31/18

     10.37†
     
    Form of Stock Appreciation Right Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.4
     
    10/31/18

     10.38†
     
    Form of Performance-Based Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    05/4/22

     10.39†
     
    Amendment to Restricted Stock Award Agreement between Douglas S. Ingram and Sarepta Therapeutics, Inc. dated December 17, 2018
     
    10-K
     
    001-14895
     
    10.75
     
    2/28/19

     10.40^
     
    Amendment No. 1 to License Agreement between Sarepta Therapeutics, Inc. and ST International Holdings Two, Inc. on the one hand and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMar